Literature DB >> 18235226

E2F1 and E2F3 activate ATM through distinct mechanisms to promote E1A-induced apoptosis.

Sungki Hong1, Qiwei X Paulson, David G Johnson.   

Abstract

Deregulation of the Rb-E2F pathway occurs in many cancers and results in aberrant cell proliferation as well as an increased propensity to undergo apoptosis. In most cases, apoptosis in response to Rb inactivation involves the activation of p53 but the molecular details of the signaling pathway connecting Rb loss to p53 are poorly understood. Here we demonstrate that the E1A oncoprotein, which binds and inhibits Rb family members, induces the accumulation and phosphorylation of p53 through the DNA damage-responsive ATM kinase. As a result, E1A-induced apoptosis is significantly impaired in cells lacking ATM. In contrast, inactivation of ARF, which is widely believed to activate p53 in response to oncogenic stress, has no effect on p53 induction and only a modest effect on apoptosis in response to E1A. Both E2F1 and E2F3 contribute to ATM-dependent phosphorylation of p53 and apoptosis in cells expressing E1A. However, deregulated E2F3 activity is implicated in the DNA damage caused by E1A while E2F1 stimulates ATM- and NBS1-dependent p53 phosphorylation and apoptosis through a mechanism that does not involve DNA damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18235226     DOI: 10.4161/cc.7.3.5286

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  9 in total

1.  Deubiquitinase USP47-stabilized splicing factor IK regulates the splicing of ATM pre-mRNA.

Authors:  Hye In Ka; Sunyi Lee; Sora Han; Ae Lee Jeong; Ji Young Park; Hyun Jeong Joo; Su Jung Soh; Doyeon Park; Young Yang
Journal:  Cell Death Discov       Date:  2020-05-04

2.  miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia.

Authors:  Deming Gou; Ramaswamy Ramchandran; Xiao Peng; Lijun Yao; Kang Kang; Joy Sarkar; Zhixin Wang; Guofei Zhou; Goufei Zhou; J Usha Raj
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-10       Impact factor: 5.464

3.  Noise induced changes in the expression of p38/MAPK signaling proteins in the sensory epithelium of the inner ear.

Authors:  Samson Jamesdaniel; Bohua Hu; Mohammad Habiby Kermany; Haiyan Jiang; Dalian Ding; Donald Coling; Richard Salvi
Journal:  J Proteomics       Date:  2011-08-16       Impact factor: 4.044

4.  E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization.

Authors:  María Llanos Valero; Francisco Jose Cimas; Laura Arias; Pedro Melgar-Rojas; Elena García; Juan Luis Callejas-Valera; Jesús García-Cano; Leticia Serrano-Oviedo; Miguel Ángel de la Cruz-Morcillo; Isabel Sánchez-Pérez; Ricardo Sánchez-Prieto
Journal:  Cell Cycle       Date:  2013-10-11       Impact factor: 4.534

5.  miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression.

Authors:  M T Pickering; B M Stadler; T F Kowalik
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

6.  Identity, proliferation capacity, genomic stability and novel senescence markers of mesenchymal stem cells isolated from low volume of human bone marrow.

Authors:  Gabrielis Kundrotas; Evelina Gasperskaja; Grazina Slapsyte; Zivile Gudleviciene; Jan Krasko; Ausra Stumbryte; Regina Liudkeviciene
Journal:  Oncotarget       Date:  2016-03-08

7.  E1A enhances cellular sensitivity to DNA-damage-induced apoptosis through PIDD-dependent caspase-2 activation.

Authors:  Jay R Radke; Zeba K Siddiqui; Iris Figueroa; James L Cook
Journal:  Cell Death Discov       Date:  2016-10-31

Review 8.  The broken cycle: E2F dysfunction in cancer.

Authors:  Lindsey N Kent; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2019-06       Impact factor: 60.716

9.  Deubiquitinase USP47-stabilized splicing factor IK regulates the splicing of ATM pre-mRNA.

Authors:  Hye In Ka; Sunyi Lee; Sora Han; Ae Lee Jeong; Ji Young Park; Hyun Jeong Joo; Su Jung Soh; Doyeon Park; Young Yang
Journal:  Cell Death Discov       Date:  2020-05-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.